| Place of Origin: | China |
|---|---|
| Brand Name: | ChineseHormone |
| Certification: | ISO9001,SGS,UKAS |
| Model Number: | 112809-51-5 |
| Minimum Order Quantity: | Free samples Available |
| Price: | Negotiable |
| Packaging Details: | Discreet package or as required |
| Delivery Time: | 3-6 working days |
| Payment Terms: | T/T, Western Union, MoneyGram,BItcoins |
| Supply Ability: | 500 kg / month |
| Assay: | 99% | Character: | White Crystalline Powder |
|---|---|---|---|
| Grade: | Pharmaceutical Grade | Packing: | Discreet Ways Of Packing For Customs Pass Guaranteed |
| Email: | Tonyraws810@gmail.com | Whatsapp: | 86-15871352379 |
| Wickr: | Tonyraws | ||
| High Light: | sex hormones drugs,natural anti estrogen |
||
99% Purity Letrozole Powder Anti Estrogen Steroids Femara CAS 112809-51-5 for Breast Cancer
| Product Name: | Letrozole |
| Synonyms: | 4,4'-(1H-1,2,4-TRIAZOL-1-YLMETHYLENE) BIS-BENZONITRILE;FEMARA;CGS-20267;LETROZOL;LETROZOLE;LetrozoleUsp28;Letrozole99%;CGS-20267, Femara |
| CAS: | 112809-51-5 |
| MF: | C17H11N5 |
| MW: | 285.3 |
| Melting point: | 181-183°C |
| Product Categories: | Anti-Cancer;Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;Letrozole;Antineoplastic;All Inhibitors;anti-neoplastic;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API's;APIs;Antibiotics;Aromatics;Heterocycles;ELOXATIN;Anti-cancer&immunity |
| Mol File: | 112809-51-5.mol |
 |
|
Usage:
Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from Letrozole include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.
Description:
Letrozole has been used for ovarian stimulation by fertility doctors since 2001 because it has fewer side-effects than clomiphene (Clomid) and less chance of multiple gestation. A Canadian study presented at the American Society of Reproductive Medicine 2005 Conference suggested that letrozole may increase the risk of birth defects.[citation needed] A more detailed ovulation induction follow-up study found that letrozole, compared with a control group of clomiphene, had significantly lower congenital malformations and chromosomal abnormalities at an overall rate of 2.4% (1.2% major malformations) compared with clomiphene 4.8% (3.0% major malformations). Despite this, India banned the usage of letrozole in 2011, citing potential risks to infants.In 2012, an Indian parliamentary committee said that the drug controller office colluded with letrozole's makers to approve the drug for infertility in India and also stated that letrozole's use for infertility was illegal worldwide; however, such off-label uses are legal in many countries such as the US and UK.
The anti-estrogen action of letrozole has been shown to be useful in pretreatment for termination of pregnancy, in combination with misoprostol. It can be used in place of mifepristone, which is expensive and unavailable in many countries.
Letrozole is sometimes used as a treatment for gynecomastia, although it is probably most effective at this if caught in an early stage (such as in users of anabolic steroids).
Letrozole has also been shown to delay the fusing of the growth plates in mice.When used in combination with growth hormone, letrozole has been shown effective in one adolescent boy with a short stature.
COA:
| product | Letrozole | ||||||||||
| Batch No | 090805 | Parking | 1kg | ||||||||
| Quantity | 5kg | Produce Date | 2016.08.02 | ||||||||
| Ref Standard | USP28 | Exp Date | 2019.08.01 | ||||||||
| Items And Results | |||||||||||
| Item | Quality level | Determination | |||||||||
| Appearance | White or off-white crystalline powder | White Crystalline powder | |||||||||
| Identification |
(1)Maximum absorption in wavelength of 240 nm |
Conform |
|||||||||
| (2)Infrared spectrum should be in accordance the dominant peak of contrast | In accordance with the dominant peak of contrast | ||||||||||
|
Solubility |
Soluble in Chloroform; |
Conform | |||||||||
| Single impurity | ≤0.3% | 0.2% | |||||||||
| Related substances | ≤0.5% | 0.3% | |||||||||
| Melting point |
181℃~183℃ |
182.3℃ | |||||||||
| Heavy metals | ≤20ppm | ≤10ppm | |||||||||
| Specific rotation | +46~ +51 | +48.5 | |||||||||
| Loss on drying | ≤0.5% | 0.21% | |||||||||
| Residue on igntition | ≤0.2% | 0.04% | |||||||||
| Assay | 97.0~101.0% | 99.1% | |||||||||
| Conclusion | Conforms Specifications of Enterprise Standard. | ||||||||||
| Operator | 3 | Checker | 2 |
Q．C |
|||||||
Applications:
Femara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer.
In women with breast cancer, it has been shown to reduce estrogen levels by 98% or more (1). However, it’s use and benefits are not limited to eliminating estrogen in women.
For pre-contest bodybuilders, Letrozole is almost a necessity to eliminate water retention and achieve the ripped look necessary to compete in today’s bodybuilding world. However, in my experience, it is only necessary to be used for the last 4-6 weeks, to eliminate excess estrogen and water retention. After using Letrozole I recommend staying away from any estrogen suppression for at least a month to try to normalize the body.
Any needs, please contact me
Email: tonyraws810@gmail.com
Whatsapp: 86-15871352379
Wickr: tonyraws
